Müller C - Search Results

1

Phenotypic effects of mutations observed in the neuraminidase of human origin H5N1 influenza A viruses.

Scheibner D, Salaheldin AH, Bagato O, Zaeck LM, Mostafa A, Blohm U, Müller C, Eweas AF, Franzke K, Karger A, Schäfer A, Gischke M, Hoffmann D, Lerolle S, Li X, Abd El-Hamid HS, Veits J, Breithaupt A, Boons GJ, Matrosovich M, Finke S, Pleschka S, Mettenleiter TC, de Vries RP, Abdelwhab EM. Scheibner D, et al. Among authors: muller c. PLoS Pathog. 2023 Feb 6;19(2):e1011135. doi: 10.1371/journal.ppat.1011135. eCollection 2023 Feb. PLoS Pathog. 2023. PMID: 36745654 Free PMC article.

2

Genetic incompatibilities and reduced transmission in chickens may limit the evolution of reassortants between H9N2 and panzootic H5N8 clade 2.3.4.4 avian influenza virus showing high virulence for mammals.

Mostafa A, Blaurock C, Scheibner D, Müller C, Blohm U, Schäfer A, Gischke M, Salaheldin AH, Nooh HZ, Ali MA, Breithaupt A, Mettenleiter TC, Pleschka S, Abdelwhab EM. Mostafa A, et al. Among authors: muller c. Virus Evol. 2020 Oct 15;6(2):veaa077. doi: 10.1093/ve/veaa077. eCollection 2020 Jul. Virus Evol. 2020. PMID: 33343923 Free PMC article.

3

Differential Impact of Specific Amino Acid Residues on the Characteristics of Avian Influenza Viruses in Mammalian Systems.

Mashaal D, Mahmoud SH, Müller C, Abo Shama NM, Kamer AA, Abdelaziz AA, Ali MA, Pleschka S, Mostafa A. Mashaal D, et al. Among authors: muller c. Pathogens. 2022 Nov 19;11(11):1385. doi: 10.3390/pathogens11111385. Pathogens. 2022. PMID: 36422635 Free PMC article.

4

Ribonuclease from Bacillus Acts as an Antiviral Agent against Negative- and Positive-Sense Single Stranded Human Respiratory RNA Viruses.

Shah Mahmud R, Müller C, Romanova Y, Mostafa A, Ulyanova V, Pleschka S, Ilinskaya O. Shah Mahmud R, et al. Among authors: muller c. Biomed Res Int. 2017;2017:5279065. doi: 10.1155/2017/5279065. Epub 2017 May 4. Biomed Res Int. 2017. PMID: 28546965 Free PMC article.

5

PA from a Recent H9N2 (G1-Like) Avian Influenza a Virus (AIV) Strain Carrying Lysine 367 Confers Altered Replication Efficiency and Pathogenicity to Contemporaneous H5N1 in Mammalian Systems.

Mostafa A, Mahmoud SH, Shehata M, Müller C, Kandeil A, El-Shesheny R, Nooh HZ, Kayali G, Ali MA, Pleschka S. Mostafa A, et al. Among authors: muller c. Viruses. 2020 Sep 20;12(9):1046. doi: 10.3390/v12091046. Viruses. 2020. PMID: 32962203 Free PMC article.

6

Bacterial ribonuclease binase exerts an intra-cellular anti-viral mode of action targeting viral RNAs in influenza a virus-infected MDCK-II cells.

Shah Mahmud R, Mostafa A, Müller C, Kanrai P, Ulyanova V, Sokurenko Y, Dzieciolowski J, Kuznetsova I, Ilinskaya O, Pleschka S. Shah Mahmud R, et al. Among authors: muller c. Virol J. 2018 Jan 5;15(1):5. doi: 10.1186/s12985-017-0915-1. Virol J. 2018. PMID: 29304825 Free PMC article.

7

Influenza virus-induced caspase-dependent enlargement of nuclear pores promotes nuclear export of viral ribonucleoprotein complexes.

Mühlbauer D, Dzieciolowski J, Hardt M, Hocke A, Schierhorn KL, Mostafa A, Müller C, Wisskirchen C, Herold S, Wolff T, Ziebuhr J, Pleschka S. Mühlbauer D, et al. Among authors: muller c. J Virol. 2015 Jun;89(11):6009-21. doi: 10.1128/JVI.03531-14. Epub 2015 Mar 25. J Virol. 2015. PMID: 25810542 Free PMC article.

8

A Novel Antiviral Strategy against MERS-CoV and HCoV-229E Using Binase to Target Viral Genome Replication.

Müller C, Ulyanova V, Ilinskaya O, Pleschka S, Shah Mahmud R. Müller C, et al. Bionanoscience. 2017;7(2):294-299. doi: 10.1007/s12668-016-0341-7. Epub 2016 Oct 20. Bionanoscience. 2017. PMID: 32219056 Free PMC article.

9

The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo.

Haasbach E, Müller C, Ehrhardt C, Schreiber A, Pleschka S, Ludwig S, Planz O. Haasbach E, et al. Among authors: muller c. Antiviral Res. 2017 Jun;142:178-184. doi: 10.1016/j.antiviral.2017.03.024. Epub 2017 Apr 2. Antiviral Res. 2017. PMID: 28377100 Free article.

10

The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo.

Müller C, Obermann W, Karl N, Wendel HG, Taroncher-Oldenburg G, Pleschka S, Hartmann RK, Grünweller A, Ziebuhr J. Müller C, et al. Antiviral Res. 2021 Feb;186:105012. doi: 10.1016/j.antiviral.2021.105012. Epub 2021 Jan 8. Antiviral Res. 2021. PMID: 33422611 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,319 results

Search Page